Associations between Minority Health Social Vulnerability Index Scores, Rurality, and Histoplasmosis Incidence, 8 US States

IF 7.2 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2024-09-11 DOI:10.3201/eid3010.231700

Dallas J. Smith, Malavika Rajeev, Kristina Boyd, Kaitlin Benedict, Ian Hennessee, Laura Rothfeldt, Connie Austin, Mary-Elizabeth Steppig, Dimple Patel, Rebecca Reik, Malia Ireland, Judi Sedivy, Suzanne Gibbons-Burgener, Renee M. Calanan, Samantha L. Williams, Sarah Rockhill, Mitsuru Toda

{"title":"Associations between Minority Health Social Vulnerability Index Scores, Rurality, and Histoplasmosis Incidence, 8 US States","authors":"Dallas J. Smith, Malavika Rajeev, Kristina Boyd, Kaitlin Benedict, Ian Hennessee, Laura Rothfeldt, Connie Austin, Mary-Elizabeth Steppig, Dimple Patel, Rebecca Reik, Malia Ireland, Judi Sedivy, Suzanne Gibbons-Burgener, Renee M. Calanan, Samantha L. Williams, Sarah Rockhill, Mitsuru Toda","doi":"10.3201/eid3010.231700","DOIUrl":null,"url":null,"abstract":"<p>To explore associations between histoplasmosis and race and ethnicity, socioeconomic status, and rurality, we conducted an in-depth analysis of social determinants of health and histoplasmosis in 8 US states. Using the Minority Health Social Vulnerability Index (MH SVI), we analyzed county-level histoplasmosis incidence (cases/100,000 population) from the 8 states by applying generalized linear mixed hurdle models. We found that histoplasmosis incidence was higher in counties with limited healthcare infrastructure and access as measured by the MH SVI and in more rural counties. Other social determinants of health measured by the MH SVI tool either were not significantly or were inconsistently associated with histoplasmosis incidence. Increased awareness of histoplasmosis, more accessible diagnostic tests, and investment in rural health services could address histoplasmosis-related health disparities.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":7.2000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3010.231700","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

To explore associations between histoplasmosis and race and ethnicity, socioeconomic status, and rurality, we conducted an in-depth analysis of social determinants of health and histoplasmosis in 8 US states. Using the Minority Health Social Vulnerability Index (MH SVI), we analyzed county-level histoplasmosis incidence (cases/100,000 population) from the 8 states by applying generalized linear mixed hurdle models. We found that histoplasmosis incidence was higher in counties with limited healthcare infrastructure and access as measured by the MH SVI and in more rural counties. Other social determinants of health measured by the MH SVI tool either were not significantly or were inconsistently associated with histoplasmosis incidence. Increased awareness of histoplasmosis, more accessible diagnostic tests, and investment in rural health services could address histoplasmosis-related health disparities.

查看原文本刊更多论文

美国 8 个州少数民族健康社会脆弱性指数得分、乡村地区和组织胞浆菌病发病率之间的关系

为了探索组织胞浆菌病与种族和民族、社会经济地位以及乡村地区之间的关联，我们对美国 8 个州的健康社会决定因素和组织胞浆菌病进行了深入分析。利用少数族裔健康社会脆弱性指数（MH SVI），我们采用广义线性混合阶跃模型分析了这 8 个州的县级组织胞浆菌病发病率（病例/100,000 人口）。我们发现，根据 MH SVI 衡量，在医疗基础设施和医疗服务有限的县以及农村县，组织胞浆菌病发病率较高。通过 MH SVI 工具衡量的其他健康社会决定因素与组织胞浆菌病发病率的关系要么不显著，要么不一致。提高对组织胞浆菌病的认识、提供更方便的诊断检测以及投资农村医疗卫生服务可以解决与组织胞浆菌病相关的健康差异问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.